Connect with us
DAPA Banner

Business

SoundHound launches self-learning AI agent platform OASYS

Published

on

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

New managing partner at law firm SAS Daniels promises ‘next chapter of growth and innovation across the North West’

Published

on

Business Live

Justine Clowes succeeds Jeremy Orrell at practice with four regional offices

The leadership team at leading North West law firm SAS Daniels LLP. Front row from left:  Paul Tyrer, Nigel Read, Steven Percy. Back row from left: Helen Kelly,  Justine Clowes

Pictured at SAS Daniels are. front row from left, Paul Tyrer, Nigel Read, Steven Percy; back row from left: Helen Kelly, Justine Clowes(Image: SAS Daniels)

Law firm SAS Daniels has named a new managing partner as part of a “significant transition in its senior leadership team”.

Justine Clowes, deputy CEO and joint head of the Macclesfield office, has succeeded Jeremy Orrell as managing partner at the firm. Meanwhile Nigel Read, head of property and joint head of the Macclesfield office, becomes senior partner.

Mr Orrell, who left the practice on April 30, qualified as a solicitor in 1983 and joined SAS Daniels in 2009. He has led the business since 2017 and has overseen growth across the practice as well as capital investments across its offices in Stockport, Chester, Macclesfield and Congleton. As a corporate lawyer, he has worked on more than 1,000 deals.

Justine Clowes said: “I am delighted to step into the role of managing partner at such an exciting time for our firm. Having worked closely with Jeremy and our talented team for many years, I am committed to building upon our strong foundations of legal excellence and client-focused service. I look forward to leading SAS Daniels into its next chapter of growth and innovation across the North West, as we look to recruit into all our legal departments and grow each of our offices.”

Advertisement

Well-known lawyer Kaye Whitby, partner and head of the SAS Daniels Chester office, is also leaving the firm.

Ms Clowes said: “On behalf of the entire team, I want to express our deepest gratitude to Jeremy and Kaye for their incredible commitment and many years of service. Jeremy’s leadership has been instrumental in our growth. We wish both Kaye and Jeremy the very best for the future.”

Her predecessor Mr Orrell said: “It has been a privilege to lead SAS Daniels and witness our collective growth over the years. I am incredibly proud of the legacy we’ve built and the exceptional talent within our firm. I wish the new board and wider team every future success.”

Three long-standing senior team members at SAS Daniels have been promoted to equity partners: Helen Kelly, partner, head of private client, and joint head of the Stockport office; Steven Percy, partner and head of commercial property; and Paul Tyrer, partner and joint head of the Congleton office. Mr Tyrer will also become head of corporate, a position previously held by Mr Orrell.

Advertisement

SAS Daniels now has 22 partners and a 120-strong specialist team.

To find all the planning applications, traffic diversions, road layout changes, alcohol licence applications and more in your community, visit the Public Notices Portal.

Continue Reading

Business

Banco BPM S.p.A. 2026 Q1 – Results – Earnings Call Presentation (OTCMKTS:BNCZF) 2026-05-05

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Strait of Hormuz tensions rise as Iran accused of ceasefire violations

Published

on

Strait of Hormuz tensions rise as Iran accused of ceasefire violations

The prospect of renewed conflict in the Middle East is intensifying as tensions escalate in the Strait of Hormuz, with military leaders warning that a return to sustained combat operations may be unavoidable following reported ceasefire violations by Iran.

TREASURY FREEZES $344M IN CRYPTO AS ‘OPERATION ECONOMIC FURY’ PUSHES IRAN TO INDUSTRIAL BREAKING POINT

Advertisement

Fox News senior strategic analyst, retired Gen. Jack Keane, joined FOX Business’ Cheryl Casone on “Mornings with Maria” to discuss the growing risks of escalation, as U.S. forces work to maintain open shipping lanes and protect commercial vessels in one of the world’s most critical energy passageways.

U.S. Navy in transit

U.S. Navy in transit in the Strait of Hormuz. (Zachary Pearson/U.S. Navy)

Keane pointed to recent Iranian actions, including reported attacks on U.S. and allied assets, as a turning point that could push the situation back into active conflict. Those developments come as the U.S. continues a large-scale operation to secure the Strait of Hormuz.

“There are two things that will likely force us to go back into combat operations… Fire on U.S. warships, that has happened, and also fire on our allies and partners in the region… That has happened as well,” Keane said.

Advertisement

TECH PRICES COULD RISE AS IRAN CONFLICT DISRUPTS ELECTRONICS SUPPLY CHAIN

The retired general emphasized that the current U.S. posture remains defensive, focused on ensuring safe passage for vessels while countering incoming threats ranging from drones to fast boats. At the same time, he underscored that Iran, not the U.S., initiated the latest round of hostilities.

“It is Iran who broke the ceasefire by firing at the ships… firing at U.S. warships… they violated the ceasefire, and we’re completely justified in responding to that,” Keane said.

Advertisement

LARRY KUDLOW: MORE BOMBING IS COMING AS IRAN PULLS OUT A BLANK PIECE OF PAPER TO TAKE TRUMPIAN DICTATION

Looking ahead, Keane warned that broader military engagement could soon follow.

“It’s inevitable that we’re going to return to combat operations here,” he said.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Advertisement
Continue Reading

Business

Harley-Davidson Q1 2026 slides: retail sales surge amid margin pressure

Published

on

Harley-Davidson Q1 2026 slides: retail sales surge amid margin pressure


Harley-Davidson Q1 2026 slides: retail sales surge amid margin pressure

Continue Reading

Business

Getting the ‘balanced dairy’ category off the ground

Published

on

Getting the ‘balanced dairy’ category off the ground

Consumers in the United States remain reluctant to embrace products that combine animal and plant-based proteins. 

Continue Reading

Business

Sourdough pizza restaurant Franco Manca confirms 16 branches to close

Published

on

Business Live

The brand’s parent firm has agreed to shut the sites as part of a company voluntary arrangement process

A Franco Manca restaurant

A Franco Manca restaurant(Image: Cambridge News)

Restaurant chain Franco Manca will push ahead with the closure of 16 venues after a restructuring plan was approved by creditors. Last month, parent firm The Fulham Shore said it planned to shut the sites as part of a company voluntary arrangement (CVA) process, which will also hit around 225 jobs.

Advertisement

The pizza brand currently runs 70 restaurants prior to the closures but said it has been knocked by “disproportionately high” UK taxes and a lack of business rates relief for restaurants. The effected restaurants were “no longer sustainable” as a result.

Franco Manca’s CVA proposal received back from more than 90 per cent of voting creditors, allowing it to get the go ahead.

Last week, Fulham Shore placed its sister restaurant brand The Real Greek into administration. It was immediately snapped up by Cote owner Karali Group but announced the close of nine of its 28 restaurants.

Marcel Khan, chief executive of Fulham Shore, said: “We are grateful for the support shown by our creditors today. Franco Manca is a fantastic brand with a strong heritage and loyal customer base.

Advertisement

“With this agreement in place, we will put the business back on a firm footing and press ahead with strengthening our customer offer and performance.”

Paul Berkovi, managing director of Alvarez & Marsal, said: “Today’s vote saw a significant majority of the company’s creditors support the CVA, reflecting constructive engagement across stakeholders.

“Against a challenging backdrop for the sector, this is an important step for Franco Manca, enabling the business to complete its financial restructuring and secure the platform for its operational transformation.”

Full list of Franco Manca branches to close

Battersea

Advertisement

Bishops Stortford

Brixton

Broadway Market

Bromley

Advertisement

Cheltenham

Chiswick

Didsbury

Glasgow

Advertisement

Hove

Kilburn

Lincoln

New Oxford Street

Advertisement

Plymouth

Stoke Newington

Tottenham Court Road

Advertisement
Continue Reading

Business

Investment fueling continued expansion for Smearcase

Published

on

Investment fueling continued expansion for Smearcase

Investment scaling startup’s expansion into 1,000 plus retailers.

Continue Reading

Business

Nissan to close UK line and cut 900 European jobs

Published

on

Nissan to close UK line and cut 900 European jobs

Nissan says it is considering working with a third party to fully utilise its Sunderland plant.

Continue Reading

Business

Tropicana adds electrolytes

Published

on

Tropicana adds electrolytes

Tropicana Hydrate is offered in two flavors. 

Continue Reading

Business

FDA Commissioner Marty Makary defends Replimune drug approval decision

Published

on

FDA Commissioner Marty Makary defends Replimune drug approval decision

Martin Makary, commissioner of the Food and Drug Administration, during a news conference at FDA headquarters in Silver Spring, Maryland, April 28, 2026.

Valerie Plesch | Bloomberg | Getty Images

U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday after months of pressure over recent drug rejections

Advertisement

The relentless heat reached a new fever pitch this week with a report from Bloomberg News detailing “paranoia, turmoil and backlash” at the agency under Makary’s tenure. An opinion piece from The Wall Street Journal asked if any administration official has created more headaches for President Donald Trump than Makary. The editorial specifically cited the FDA’s controversial rejection of a drug candidate for melanoma from Replimune

“I think that article in The Wall Street Journal is the ninth article they’ve posted in that opinion section, begging for Replimune’s approval,” Makary said in an interview with CNBC’s David Faber. “I don’t work for Replimune, I work for the American people, and I stand by the scientists at the FDA.”

Makary said three independent teams have arrived at the same conclusion, adding that the FDA has not made “corrupt sweetheart deals.” Replimune representatives have said the FDA has unfairly treated the company. 

Makary said he stands behind his review teams and that FDA commissioners overruling agency scientists has been a “disaster” every time it has happened. He cited examples like the FDA’s approval of an Alzheimer’s disease drug called Aduhelm and its clearance of a Covid-19 vaccine booster for young, healthy kids. 

Advertisement
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Trending

Copyright © 2025